Christine Barbon serves as Principal Scientist at Bluefin BioMedicine, where she leverages her extensive expertise in disease research and translational science to drive innovative projects in cancer and autoimmune inflammatory immunology. With a robust background in both industry and academia, Christine excels in the design...
Christine Barbon serves as Principal Scientist at Bluefin BioMedicine, where she leverages her extensive expertise in disease research and translational science to drive innovative projects in cancer and autoimmune inflammatory immunology. With a robust background in both industry and academia, Christine excels in the design and execution of in vitro and in vivo studies aimed at elucidating the efficacy, mechanism of action (MOA), and safety profiles of novel therapeutic molecules. Her work is pivotal in advancing the understanding of complex disease mechanisms, particularly in the realms of cancer research and autoimmunity.
At Bluefin BioMedicine, Christine is currently leading key projects that focus on the development of cutting-edge therapies targeting various cancers and autoimmune disorders. Her proficiency in radiation biology, cell biology, and gene therapy underpins her approach to drug discovery, allowing her to effectively navigate the intricacies of assay development and antibody engineering. Christine's passion for translating scientific discoveries into practical applications drives her commitment to developing tools that enhance our understanding of disease pathology and therapeutic interventions.
In addition to her technical acumen, Christine's leadership skills are instrumental in fostering collaborative environments that encourage innovative thinking and problem-solving. Her ability to synthesize complex data and translate it into actionable insights positions her as a thought leader in the field. With a keen focus on lysosomal storage disease research and the broader implications of her work, Christine Barbon continues to make significant contributions to the biomedical landscape, striving to bridge the gap between laboratory research and clinical application.
